Navigation Links
LOGIX in Medical News

Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes

BOSTON, March 9 /PRNewswire/ -- Surface Logix today announced that it has raised over $20 million in a combined equity and debt financing. The Company raised approximately $15 million through equity contributions by existing investors, including ARCH Venture Partners, HBM BioVentures, Healthcare ...

Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease

BOSTON, -- Surface Logix Inc. today announced the initiation of a Phase 2a clinical trial for SLx-2101 in patients with secondary Raynaud's disease. SLx-2101 is a novel , long-acting PDE-5 inhibitor being developed for the management of diseases associated with vascular dysfunction such as Raynaud'...
LOGIX in Medical Technology

Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension

BOSTON, Jan. 8 /PRNewswire/ -- Surface Logix today announced positive results in the Company's Phase 2a clinical trial of SLx-2101 in hypertension. The randomized, double-blind, placebo-controlled crossover Phase 2a study in 60 patients with uncontrolled hypertension demonstrated that SLx-2101...

Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism

BOSTON, Oct. 5 /PRNewswire/ -- Surface Logix, Inc. today announced the presentation of positive safety and efficacy data from its innovative Phase 1 repeat-dose clinical trial of its investigational drug candidate SLx-4090, a first-in-class enterocyte-specific microsomal triglyceride transfer ...

Surface Logix, Inc. to Present at the Piper Jaffray Health Care Conference

...n will take place on Wednesday, November 28, 2007 at 2:50 PM EST. Surface logix currently has two programs in human clinical trials with a third program in...www.surfacelogix.com . Contact: Leland Webster, Ph.D., M.B.A. Surface logix Inc. Vice President, Corporate Development 617.746.8520 Media: Sarah C...
LOGIX in Biological Technology

Surface Logix Appoints Keith Dionne as President and Chief Executive Officer

BOSTON, Oct. 14 /PRNewswire/ -- Surface Logix, a privately held biopharmaceutical company focused on using biophysical chemistry to create and develop novel small molecule drugs, is pleased to announce the appointment of Keith Dionne, Ph.D. to the position of President and Chief Executive Offi...

Surface Logix Announces Executive Management Changes

BOSTON, May 15 /PRNewswire/ -- Surface Logix today announced that Jim Mahoney, President & CEO, will be stepping down from his current position to pursue other interests. Mr. Mahoney will maintain a consulting relationship with the company for the foreseeable future. Steven Gillis, Ph.D., Mana...

Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial

BOSTON, Jan. 29 /PRNewswire/ -- Surface Logix today announced positive results in the Company's Phase 2a clinical trial of SLx-4090 in dyslipidemia (high cholesterol and triglyceride levels in the bloodstream). The randomized, double-blind, placebo-controlled Phase 2a study in 24 patients with...

NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director

... of Dobson Communications, sitting on both the Audit and Compensation Committees, through the 2007 sale of Dobson to AT&T. He was President and CEO of logix Communications, a Competitive Local Exchange Carrier operating primarily in Texas and Oklahoma, from 1999 through 2001. Following that he spent two ye...
LOGIX in Biological Products

APO LOGIX - JC-1 Mitochondrial Membrane Potential Detection Kit from BACHEM

Description: In situ detection of apoptosis and mitochondrial membrane potential. The mitochondrial permeability transition event provides an early indication of the initiation of cellular apoptosis. This process is typically defined as a collapse in the electrochemical gradient across the mitochondrial membran...
Company:BACHEM
Other Tags
(Date:3/6/2015)... As the Association of American ... 90,000 doctors by 2025 is updated this week and ... is proactively preparing by analyzing demographics and pursuing viable ... , Several factors including the increasing number of retiring ... the Affordable Care Act and an uneven distribution of ...
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued ... (or someone you know) have chronic pain and problems ... interested in the ACT-OA clinical trial. , Kevin ... is one of fifteen physicians in the U.S. to ... as part of a new, multi-site, double blind, placebo-controlled ...
(Date:3/6/2015)... March 06, 2015 Utilizing the latest ... rapidly reach their ideal weight has enabled Diet Doc ... to their already impressive collection of fat loss enhancement ... clients special promotions and savings to help people throughout ... This promotion is especially appealing to new clients ...
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 ... publishing company, created a unique ‘energy’ experiment to ... lives. , After quick ‘5 -7 ... more than 150+ countries reported their life improving ... respondents reported positive results. , According to research, ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Dr. Mark Sowell ... Education in Scottsdale, AZ. Offering programs for advanced education in ... over the world. , As a visiting faculty member ... “teach and learn” each time he visits Spear Education to ... Dr. Sowell remarks, “we are training only the top 10% ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 3Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 4Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... forecasts are provided for the period 2013 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2
Other Contents